These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33124647)

  • 1. Comparing New-User Cohort Designs: The Example of Proton Pump Inhibitor Effectiveness in Idiopathic Pulmonary Fibrosis.
    Tran T; Suissa S
    Am J Epidemiol; 2021 May; 190(5):928-938. PubMed ID: 33124647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis.
    Kreuter M; Ehlers-Tenenbaum S; Palmowski K; Bruhwyler J; Oltmanns U; Muley T; Heussel CP; Warth A; Kolb M; Herth FJ
    PLoS One; 2016; 11(3):e0151425. PubMed ID: 27023440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-user and prevalent-user designs and the definition of study time origin in pharmacoepidemiology: A review of reporting practices.
    Luijken K; Spekreijse JJ; van Smeden M; Gardarsdottir H; Groenwold RHH
    Pharmacoepidemiol Drug Saf; 2021 Jul; 30(7):960-974. PubMed ID: 33899305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalent new user designs: A literature review of current implementation practice.
    Tazare J; Gibbons DC; Bokern M; Williamson EJ; Gillespie IA; Cunnington M; Logie J; Douglas IJ
    Pharmacoepidemiol Drug Saf; 2023 Nov; 32(11):1252-1260. PubMed ID: 37309989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease latency and new-user versus prevalent-user cohort designs: Implications for pharmacoepidemiology in dementia.
    Wu CY; Swardfager W
    J Am Geriatr Soc; 2024 Mar; 72(3):953-955. PubMed ID: 38147492
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to: Disease latency and new-user versus prevalent-user cohort designs: Implications for pharmacoepidemiology in dementia.
    Lee AK; Lee SJ; Dublin S
    J Am Geriatr Soc; 2024 Mar; 72(3):956-957. PubMed ID: 38147504
    [No Abstract]   [Full Text] [Related]  

  • 7. Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis.
    Skurikhin E; Nebolsin V; Widera D; Ermakova N; Pershina O; Pakhomova A; Krupin V; Pan E; Zhukova M; Novikov F; Sandrikina L; Morozov S; Kubatiev A; Dygai A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular approach to the classification of chronic fibrosing lung disease-there and back again.
    Verleden SE; Braubach P; Kuehnel M; Dickgreber N; Brouwer E; Tittmann P; Laenger F; Jonigk D
    Virchows Arch; 2021 Jan; 478(1):89-99. PubMed ID: 33169196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis.
    Wang Y; Yella JK; Ghandikota S; Cherukuri TC; Ediga HH; Madala SK; Jegga AG
    Ther Adv Respir Dis; 2020; 14():1753466620971143. PubMed ID: 33167785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-acting isomer of Ac-SDKP attenuates pulmonary fibrosis through SRPK1-mediated PI3K/AKT and Smad2 pathway inhibition.
    Qiu Y; Wang Z; Zhang X; Huang P; Zhang W; Zhang K; Wang S; He L; Guo Y; Xiang A; Zhang C; Hao Q; Li M; Li W; Zhang Y
    IUBMB Life; 2020 Dec; 72(12):2611-2626. PubMed ID: 33135306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
    Funke-Chambour M
    Ann Am Thorac Soc; 2020 Nov; 17(11):1378-1379. PubMed ID: 33124912
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a Patient Support Program for Idiopathic Pulmonary Fibrosis Patients on Medication Persistence: A Retrospective Database Analysis.
    Near AM; Burudpakdee C; Viswanathan S; Kaila S
    Adv Ther; 2021 Jul; 38(7):3888-3899. PubMed ID: 34057677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social Media Content of Idiopathic Pulmonary Fibrosis Groups and Pages on Facebook: Cross-sectional Analysis.
    Kochan A; Ong S; Guler S; Johannson KA; Ryerson CJ; Goobie GC
    JMIR Public Health Surveill; 2021 May; 7(5):e24199. PubMed ID: 34057425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assisting People With Their Living, Not Their Dying: Health Professionals' Perspectives of Palliative Care and Opioids in ILD.
    Russo L; Willis K; Smallwood N
    Am J Hosp Palliat Care; 2022 Feb; 39(2):211-219. PubMed ID: 34056929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial.
    Martinez FJ; Yow E; Flaherty KR; Snyder LD; Durheim MT; Wisniewski SR; Sciurba FC; Raghu G; Brooks MM; Kim DY; Dilling DF; Criner GJ; Kim H; Belloli EA; Nambiar AM; Scholand MB; Anstrom KJ; Noth I;
    JAMA; 2021 May; 325(18):1841-1851. PubMed ID: 33974018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micellar Hyaluronidase and Spiperone as a Potential Treatment for Pulmonary Fibrosis.
    Skurikhin E; Madonov P; Pershina O; Ermakova N; Pakhomova A; Widera D; Pan E; Zhukova M; Sandrikina L; Artamonov A; Dygai A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD.
    Shumar JN; Chandel A; King CS
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34070297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?
    Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Richeldi L; Corsico AG
    Cells; 2021 May; 10(5):. PubMed ID: 34068958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Living with Pulmonary Fibrosis questionnaire in progressive fibrosing interstitial lung disease.
    Swigris J; Cutts K; Male N; Baldwin M; Rohr KB; Bushnell DM
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34046493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat bronchoalveolar lavage in idiopathic pulmonary fibrosis: proceed with caution?
    Jones MG; Kolb M
    Eur Respir J; 2021 May; 57(5):. PubMed ID: 34045285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.